| INN name: | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Lab Code(s): |
find at Drugspider
| ||||||||
| Chemical name: |
2-{[2-(3-Butoxyphenyl)ethyl]amino}-N,N-dimethylacetamide
| ||||||||
| Chemical structure: |  | ||||||||
| Molecular formula: |
C16H26N2O2
| ||||||||
| CAS registry number: |
1092977-61-1
| ||||||||
| Originator: |
Newron Pharmaceuticals
| ||||||||
| Class: |
Antidepressants
Antiepileptic drugs
Antimanics
Antipsychotics
Non-opioid analgesics
| ||||||||
| Mechanism of action: |
Nav1.3 voltage-gated sodium channel inhibitors
Nav1.7-voltage-gated-sodium-channel-inhibitors
Nav1.8 voltage-gated sodium channel inhibitors
| ||||||||
| WHO ATC code(s): |
N02 (Analgesics)
N03A (Antiepileptics)
N05A (Antipsychotics)
N05B (Anxiolytics)
N07X (Other Nervous System Drugs)
| ||||||||
| EPhMRA code(s): |
N2 (Analgesics)
N3 (Anti-Epileptics)
N5A (Antipsychotics)
N5B (Hypnotics/Sedatives)
N6A (Anti-Depressants and Mood Stabilisers)
N7X (All other CNS drugs)
| ||||||||
| Clinical trial(s): |
|
Sunday 11 October 2015
Evenamide
Subscribe to:
Posts (Atom)